Covid-19: Arthritis drug trial for severe illness is stopped early after increase in deaths
New trial finds arthritis drug tocilizumab no better than standard care for severe COVID-19
20 January 2021Seven days in medicine: 13-19 January 2021
21 January 2021Covid-19: Arthritis drug trial for severe illness is stopped early after increase in deaths
A trial testing whether the arthritis drug tocilizumab plus standard care could improve outcomes for patients with severe or critical covid-19 has been stopped early after an increase in deaths.1Just…
